Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP4F2 Variants and Diclofenac Side Effects
NCT02779530Phase 4Completed
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pain and inflammation comparing Diclofenac with Placebo (2 arms). Primary endpoint: Edema at 6 days. Started Oct 2011; status: completed.
02
Drugs
diclofenac
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT02779530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779530.